Among gastrointestinal (GI)-distributed isozymes encoded at the UGT1 locus, UGT1A10 metabolized a number of important chemicals. Similar to broad conversion of phytoestrogens [Basu et al., J. Biol. Chem.279, 1429 -1441 (2004 ], UGT1A10 metabolized estrogens and their derivatives, whereas UGT1A1, 1A3, 1A7, and 1A8 differentially exhibited reduced activity toward the same.
1A10, compared with 1A7, 1A8, and 1A3, generally exhibited high activity toward acidic nonsteroidal antiinflammatory drugs and natural benzaldehyde derivatives, while 1A3 metabolized most efficiently aromatic transcinnamic acids known to be generated from flavonoid-glycosides by microflora in the lower GI tract. Finally, UGT1A10, 1A7, 1A8, and 1A3 converted plant-based salicylic acids; methylsalicylic acid was transformed at high levels and acetylsalicylic-(aspirin) and salicylic acid at moderate to low levels. Atypically, UGT1A10 transformed estrogens between pH 6 and 8, but acidic structures preferentially at pH 6. Also, a variety of simple phenols are generated in the GI system from plant constituents (9, 10) .
Flavonoid-glycosides reach the lower GI tract where the microflora both hydrolyze the glycosides and further metabolize free flavonoids to form a range of aromatic chemicals (9) . The metabolites include various aromatic acids and aldehydes as break-down products. Hence, absorption of ingested chemicals and those generated in the GI determine chemical exposure. As these lipophiles are both simple and polyaromatic containing hydroxyl and/or carboxyl group(s), they are potential substrates of UDP-glucuronosyltransferase (UGT) isozymes, which convert chemicals to glucuronides to enhance water solubility and excretion from cells. To that end, the cluster---UGT1A1, 1A7, 1A8, 1A9, and 1A10---of the human UGT1-encoded isozymes (11) was recently shown to be differentially distributed throughout the GI, but strategically located in the mucosal layer of tissues (12) . The observation that the Gunn rat model (UGT1 -/-) is 100-fold more sensitive to acetaminophen than the wild-type Wistar rat (13) indicates glucuronidation is protective against chemical toxins.
Because UGT1A10 --among the isozyme-cluster--was effective in metabolizing all categories of phytoestrogens (12) , it suggested the isozyme would also metabolize structurally similar endogenous estrogens. Furthermore, the high abundance of the isozyme in the lower-GI led to speculation it may play a role in converting aromatic acids formed in that region by microflora, as well as convert ingested therapeutic acidic drugs.
In this study, we show UGT1A10 glucuronidated 3 different categories of chemicals including estrogens, plant-based cinnamic-and aromatic-acid structures, nonsteroidal antiinflammatory drugs, and salicyclic-acid derivatives. While UGT1A10 was the primary metabolizer, studies showed differential overlapping activity with UGT1A1, 1A3, 1A7, and 1A8. The isozyme exhibited different pH optima for catalysis, and it showed a dependency on phosphorylation that is linked to protein kinase C (PKC). Additionally, UGT1A10-transfected COS-1-cell cultures glucuronidated Preparation of Microsomes-Human tissue adjacent to that used for in-situ analysis (12) was snap-frozen and stored at -80 C until microsomes were prepared (14) . Microsomes were resuspended in phosphate buffered saline and stored at -80 C until UGT was analyzed.
Source of UGT1A1, 1A7, 1A8, and 1A10 expression units-
The pSVL-based UGT1A1 expression unit was previously described (15) . UGT1A7, 1A8, and 1A10 were constructed as described (12) .
Similarly, UGT1A3 and 1A5 were constructed using the UGT1A4-cDNA (15) as template instead of UGT1A9-cDNA and an appropriate genomic subclone as described (12) .
Transfection of UGT1cDNA-expression Units into COS-1 cells-All cDNA expression units were transfected into COS-1 cells using DEAE-Dextran as the carrier (15) .
Western Blot Analysis of UGT-cDNA-dependent Expression-To establish the relative amounts of each UGT protein, an antibody (16) prepared by Veritas (Rockville, MD) was raised in rabbit against the common 245-amino acid carboxyl-peptide present in each UGT1-encoded isozyme and used for Western blot analysis (16) . pSVL-based cDNA-dependent expression of UGT1A1, 1A3, 1A7, 1A8, or 1A10 protein in COS-1 cells was harvested 72 hr after transfection; 100 g cellular protein was prepared and electrophoresed in a 7.5 or 15 % polyacrylamide-SDS gel and electrotransblotted onto nitrocellulose membranes, which were processed as described (16) . Proteins were visualized by immunoreacting with rabbit anti-UGT1 and goat anti-rabbit second antibody-HRP-conjugate according to the ECL protocol (Amersham Life Science, Arlington Heights, IL), which exposed x-ray films for development and quantitation.
Assay for Glucuronidation of Chemicals by UGT1A1, 1A3, 1A7, 1A8, and 1A10-The modified glucuronidating assay system has been described (17, 18) . The common donor substrate, UDP-[ 14 C]glucuronic acid (1.41 mM, 1.4 Ci/ mol), was used in all in-vitro reactions with an unlabeled acceptor/aglycone substrate. Similar to reactions for Km determinations, pH profiles reflect product generated in 2 hr at 37 C with 300 g protein from pSVL(UGT)-transfected COS-1 cells. Linear glucuronidation reactions for substrate screens were conducted at both pH 6.4 and 7.6 over 4 hr and defined as glucuronide accumulated/4 hr as described (19) . All chemicals were solubilized in fresh DMSO.
Mutagenesis of Predicted PKC Phosphorylation Sites in UGT1A10-
Site-directed mutagenesis at amino acid 73, 202 or 432 in UGT1A10 was carried out as described (18) . Oligos for converting the common PKC site, S432G, in UGT1A10 were: sense (214C) (5-ctgcttggtcacccgatgaccc-3) and antisense (463C) (5-ggcgcatgatgttctccttgtaacctttg-3) for fragment 1 and sense (435C) (5-caaaggttacaaggagaacatcatgcgcc-3) and antisense (BamH1Stop) (5-cccggatccacccacttctcaatgggtctt-3) for fragment 2. For T73A mutation of UGT1A10, primers were: sense Xho1A10S (5-ccctcgagggagctgctggctcgggct-3) and antisense 73A10AS (5-cgaggttgagtaagtcttcactgcgca-3) for fragment 1; for its overlapping unit, the sense was the complement of 73A10AS, and the antisense was PXAS6 (18) . Finally, for T202A mutation for UGT1A10, primers were: sense Xho1A10S and antisense 202A10AS (5-ccatactctctccttgaaagccatggcatc-3), and its overlapping fragment was synthesized using the complement of 202A10AS as sense and PXAS6 as antisense. After samples were boiled in SDS sample-buffer to detach protein, each sample was spun through a microSpin column (Amersham, Piscataway, NJ) to remove beads. Duplicate sets of radiolabeled UGT1A10 and mutants were electrophoresed in a SDS-7.5 % polyacrylamide gel; one gel was processed for exposure to x-ray film, and the duplicate gel was analyzed by Western blot as described above. Samples were vacuum-dried, resuspended in 70 % ethanol, and applied to TLC plates for elution as described (18) for quantitation (19) .
RESULTS

Glucuronidation of Epigallocatechin 3-O-gallate, 17 -Estradiol, and Flurbiprofen by
Microsomes isolated from Human GI-tissues-To gain insight into the function of the UGT1-encoded isozymes, we previously compared their pattern of tissue-distribution and cellular location by Northern blot analysis and in-situ hybridization of messenger RNAs (12) . We found UGT1A10 is primarily distributed in the mucosal layer of the GI tract below the stomach (12) with substantial amounts in other tissues. We also used microsomes prepared from adjoining tissue to that used for in-situ hybridization in conjunction with the highly specific UGT1A10-substrate, epigallocatechin 3-O-gallate (ECG) (see reference 12), to assess its relative level of activity in GI tissues.
[Determination of substrate specificity was based on a screen of 40 chemicals using recombinant UGT1A1, 1A7, 1A8, 1A9, and 1A10 (12) at both pH 6.4 and 7.6. Under similar conditions and for a given substrate, isozyme specificity was determined as the ratio of an isozyme-activity to the sum of all isozyme-activities.] In this study with GI microsomes, we compared ECG with two other UGT1A10-substrates, flurbiprofen (pH 6.4) and 17 -estradiol (pH 7.0), which were 83-and 89 %-specific, respectively. UGT 1A10 appeared to be present in duodenum:ileum:colon:stomach:esophagus at relative levels of 9:8:3:2:1 ( Fig. 1 ). While the isozyme was most abundant in small and large intestines, which was followed by stomach, and it showed greater turnover of 17 -estradiol than ECG and flurbiprofen, it appeared detectable in esophageal microsomes by substrate analysis. Although UGT1A8 was detectable only in the stomach by Northern blot analysis (12) , glucuronidation studies with phloretin at pH 7.0 and in-situ hybridization with specific probes demonstrated moderately high to high levels in esophagus, duodenum, ileum and colon (12) . Except for stomach, UGT1A8 is concentrated in a highly erratic pattern in limited regions of all GI tissues. UGT1A7, on the other hand, was highest in esophagus and at low to intermediate levels in nearly every tissue with the highest level in thyroid and adrenal glands (12) . While Northern blot detected UGT1A3 only in liver (unpublished data), it was shown that the isozyme, like UGT1A8 (12), can be found in GI tissues following RT-PCR amplification of mRNA (23) . In a recent study with bilirubin as UGT1A1-specific substrate (12), we found 1A1 was distributed in duodenum, ileum and stomach at relative levels of appoximately 10:4:1 with activities expressed as pmol/hr/mg prot.
Western Blot Analysis of UGT1A1-, 1A3-, 1A7-, 1A8-, and 1A10-expressed in COS-1 cells-To
normalize the relative levels of UGT proteins, we carried out Western blot analysis (Table 1A) with the UGT1A common-end antibody (16) , and the relative levels of UGT1A1, 1A3, 1A7, 1A8, and 1A10 synthesized in COS-1 cells were determined by scanning blots with a UMAX system and quantifying with Adobe Photoshop software. After normalizing relative protein levels, specific activities were calculated and are shown. >10-fold greater activity than 1A1 (Fig. 3) .
Glucuronidation of Estrogens, Plant-derived Aromatic Acids, and Nonsteroid Anti-inflammatory
Drugs by UGT1A10, 1A1, 1A3, 1A7, and 1A8-In an earlier study (12) , we observed that UGT1A10 metabolized two different types of phytoestrogens nearly equally at both pH 6.4 and 7.6.
Furthermore, we found that UGT1A4, 1A5, 1A6, 1A9, UGT2B7 and 2B15 did not show a significant activity toward the primary estrogens (data not shown) (26) , although recombinant 2B7
was previously reported to have detectable activity when microsomes were analyzed (24) . Since phytoestrogens and mammalian estrogens often exhibit similar actions and show competitive interactions via the estrogen receptor (1,6), we compared the metabolism of endogenous estrogens by UGT1A10 to that by 1A8, 1A7, 1A3, and 1A1 using equal specific protein (Table 1A) . Eight out of 9 estrogens, including their derivatives, were excellent substrates for UGT1A10 at both pH 6.4 and 7.6 (Table 1B) . UGT1A10, 1A8, 1A7, and 1A3 showed a 5 to >10-fold preference for the predictably more hydrophobic 2-CH 3 O(methoxy)-estradiol than 2-OH(hydroxyl)-estradiol; similarly, this enzyme set exhibited from 6-to 17-fold greater preference for 4-OH-estrone than 2-OH-estrone. UGT1A10 showed exceptional and equally high activity towards 3 estriol isomers, which contained 3 different versions of 16-and 17-hydroxyls that project in versus out of the plane of the core steroid structure (see Table IB ); the estriols turnover were only some 23 to 30% less than that for estrone and 2-CH 3 O-estradiol, which gave the highest activities for steroids. UGT1A8
showed more than 4-fold preference for the 16,17-estriol than 17-estriol. Interestingly, the two least effective estrogenic substrates--2-OH-estradiol and 2-OH-estrone --for UGT1A10 were converted at the highest level by UGT1A1, which was 2.5-to 4.5-fold higher than by 1A10. Hence, the two 11 by guest on December 31, 2017
http://www.jbc.org/ Downloaded from isozymes showed complementary activity toward the 2-OH estrogens, and, overall, UGT1A10 was superior to 1A1, 1A8, 1A7, and 1A3 in metabolizing estrogens.
With few exceptions, all isozymes metabolized the estrogens and their derivatives nearly equally under both pH conditions, suggesting a broad pH optimum as seen in Fig. 2A for 17 -estradiol.
UGT1A9 inefficiently metabolized certain estrogen derivatives at either pH 6.4 or 7.6 (Legend of Table I ).
In a previous report (12) , UGT1A10 was shown to glucuronidate 32/40 chemicals with a 1.5 to 10-fold preference for pH-6.4 optimum. Substrates included anthraquinones and related chemicals, flavonoids/isoflavones (phytoestrogens) and related chemicals, polycyclic aromatic hydrocarbonand simple-phenols, and lactone-containing phytoestrogens. In contrast, UGT1A10 converted 7/8 estrogens (this study) and 6/7 phytoestrogens (12) nearly equally at pH 6.4 and 7.6; only estrogenic 2-OH-estradiol and phytoestrogenic daidzein showed a pH-6.4 preference. Among the 40 chemicals (12), UGT1A10 metabolized isoflavones or phytoestrogens the most efficiently; UGT1A7 had comparably high turnover for the lactone-containing phytoestrogens (coumestrol and zearalenone) and the isoflavan, equol. Among estrogenic compounds, UGT1A3 effectively conjugated only 2-
Because UGT1A10 exhibited a high activity toward many dietary agents, including phytoestrogens (12), and it is distributed primarily in GI mucosa from duodenum through colon, we carried out substrate analysis on carboxyl-containing chemicals known to form in the lower GI tract by microflora from flavonoids found in high levels in our plant-based diet (9) or to be ingested as dietary constituents or as therapeutic agents such as NSAIDs. Studies with such substrates, which included salicylates, transcinnamic acids, ß-phenylpyruvic through diphenyl/biphenyl acids, as well as 14 therapeutic NSAIDs (Tables II and III) (Table II) showing only 6 to 37 % the activity for the best aldehyde analog.
Also UGT1A10 expressed the highest conversion of transcinnamic acids, including caffeic and ferulic acids at pH 6.4. For the pyruvic, propionic-, and isovaleric-phenyl acids (Table II ), UGT1A3 showed approximately 2-fold greater activity than other isozymes. Diphenyl-and biphenyl acetic acids, with free rotation of phenyl groups versus fixed groups, were metabolized nearly equally by the isozymes examined.
Results with therapeutic polyaromatic acids, NSAIDs (Tables II and III), show UGT1A10 converted mefenamic acid, diflunisal, flurbiprofen, fenoprofen, ibuprofen, and indomethacin at levels comparable to the vanillins and certain estrogens, but with pH 6.4 preference. Overall, UGT1A3 metabolized the NSAID at a moderate level with pH 6.4 preference, except for indoprofen.
It is notable that the nonacidic, but aromatic acetaminophen is not a substrate for either of these isoforms or a poor substrate for UGT1A3 and UGT1A10.
There are other significant observations concerning glucuronidation of these chemicals. While UGT1A1 metabolized certain estrogens, it did not metabolize any of the aromatic acids in this study. predicted PKC phosphorylation sites in each protein (21) . Consistent with these findings and under conditions of equal protein (Fig. 4, top panel) , the radiogram ( It is also evident that a major radiolabeled species and a barely detectable one are present in the nascent UGT1A10 evidently reflecting on-going protein maturation due to glycosylation at 3 predicted glycosylation sites as previously seen for other UGTs (26) . A minor band at the top is not distinguishable by Western blot analysis.
In-vitro Glucuronidation by COS-1 Cells Transfected with Wild-type or UGT1A10 Mutants-
Since UGT1A10 exhibited high activity towards estrogens (Table 1B) , phytoestrogens (12) , and
NSAIDs (Tables II and III) , we examined the effect of independent, double and triple mutations on the capacity of UGT1A10 to glucuronidate 17 -estradiol, genistein, and flurbiprofen. The isozyme exhibited the greatest activity towards the phytoestrogen, genistein, followed by 17 -estradiol and flurbiprofen (Fig. 5) . Its Km for genistein (not shown) is similar to that for 17 -estradiol and flurbiprofen (Fig. 2) . Furthermore, the T73A, T202A, and their double mutant, T73A/T202A, exhibited null activity for each substrate. The S432G mutant caused an increase in activity for each of the substrates, and its double mutant with either T73A or T202A showed Among the isozymes encoded at the UGT1 complex locus, UGT1A10, distributed primarily in the GI tract (12) with significant levels in heart, placenta, spleen, pancreas, lymphnode, adrenal, and uterus, expressed more than 10 and 100-fold higher activity toward the primary estrogens, 17 -estradiol and estrone, respectively, than UGT1A1 (Table 1B) . Moreover, UGT1A10 metabolized all estrogen derivatives tested at 16-to more than 10,000-fold higher rates than 1A1, except for 2,3-catechol estrogens. With an inverse pattern, UGT1A1 metabolized 2-OH-estradiol and 2-OH-estrone at rates 2-and 4.5-fold higher, respectively, than UGT1A10. Overall, this study shows that UGT1A10 metabolized estrogens at a higher level than other UGT1A isozymes and with an atypically broad pH range compared to its high pH-6.4 preference observed for a screen of 40 test chemicals (12) . It is notable that UGT2B7 metabolized many estrogen derivatives (26-28), but not estrone or 17 -estradiol (data not shown here) (26) , except 2B7 did show activity using microsomes isolated from a different expression system (24) . The ineffectiveness of UGT1A1 at converting 17 -estradiol compared to the high level of conversion by 1A10 in cell culture suggests it is most likely responsible for glucuronidating endogenous estrogens, despite its high Km value. Thus, UGT1A10
appears to be unique in carrying out significant transformation of the primary estrogen, 17 -estradiol.
Interestingly, we discovered earlier that UGT1A10 also metabolized several categories of phytoestrogens (12): the isoflavone-type (daidzein, genistein, formononetin, and biochanin A), an isoflavan-type (equol), lactone-containing compounds (coumestrol and zearalenone) and estrogenic flavonoid precursors (5) [phloretin and others (12)] with a broad pH range and at a level comparable to the estrogens described in this study. Among 4 different categories of chemicals (12) and after eugenol, phytoestrogens were the most highly preferred class of substrates by UGT1A10.
Phytoestrogens, like catechol estrogens (26, 27) , are estrogenic due to structural similarities, which allow competition at the level of the estrogen receptor (1, 5) . As UGT1A10 metabolized 17 -estradiol in vitro at low concentrations (2 to 20 M) to a high extent, unlike 1A1, it is likely that 1A10 is adapted to convert both estrogens and dietary phytoestrogens, despite its Km (64 M), but broad pH range (Fig. 2) . The devastation that phytoestrogens can inflict on the reproductive systems of livestock that consume large quantities of clovers with high phytoestrogen content (2) underscores the potential damage these agents can impose via interaction with the estrogen receptor and the need to limit their GI-absorption. Predictably, GI-distributed UGT1A10, which is the most effective at converting these dietary phytoestrogens in vitro, is adapted to allow humans to limit their absorption to reduce the risks of reproductive failures.
A striking feature of ingested test-flavonoids was demonstrated by a lack of absorption even when taken in high levels (8, 9) . The possibility existed that the chemicals undergo catabolism in the lower GI tract by microflora (9) as suggested by many aromatic acids derived from flavonoids found in urine of treated animals (9). Our examination of flavonoid-and catechin-derived catabolic acids uncovered their capacity to undergo glucuronidation. Unexpectedly UGT1A3, detectable in GI tissue by RT-PCR (23) and at moderate levels in liver by Northern blot analysis (unpublished data), showed significant glucuronidation of simple aromatic acids, such as pyruvic-, propionic-, isovaleric-, cinnamic-(caffeic, ferulic) and benzoic acid (vanillic), as well as a benzaldehydecontaining metabolite of flavonoids, produced by microflora in the lower gut (10). The two benzaldehydes were metabolized, at least, an order of magnitude better by UGT1A10, 1A8, or 1A7 than by UGT1A3. Generally, the evidence shows that acid-containing flavonoid metabolites are most effectively metabolized by UGT1A10 and 1A3.
Additionally, we compared the more complex carboxyl-containing therapeutic NSAIDs with the simple plant-derived acids. While UGT1A10 was superior to the other isozymes in converting NSAIDs --as demonstrated by mefenamic acid and diflunisal (Table III) --, 1A8, 1A7, and 1A3 also avidly transformed mefenamic acid. Diclofenac was preferred by UGT1A3. UGT1A10 and 1A7 transformed the related acidic structure, furosemide. In summary, UGT1A10 appears to be the primary isozyme for converting both simple and polycyclic aromatic acids. Despite the essentially unique capacity of UGT1A1 to metabolize the endogenous acid, bilirubin (15) , it was completely ineffective with exogenous acids in this study. Although catalysis by UGT1A3 did not reach the level observed for 1A7, 1A8 and 1A10, it is possible that over time its conversions under in-vivo conditions have an impact.
As biphenyl acetic acid, mefenamic acid, flurbiprofen, fenoprofen, ibuprofen, and indomethacin, and a list of other test-chemicals in this study had acidic groups but lack a hydroxyl group for glucuronide formation and were exceptional substrates for UGT1A10, the results demonstrate 1A10
is likely the major catalyst for forming carboxyl-linked glucuronides and not UGT1A3. Also, the high activity with methysalicylate and poor activity with salicylate indicates the absence of intramolecular hydrogen-bonding between hydroxyl and carboxyl substituent groups has a highly positive effect on metabolism by UGT1A10. Inability to form intramolecular hydrogen-bonding in the highly effective substrates, aldehyde-containing vanillin and o-vanillin compared to ferulic and vanillic acid (Table II) , is further evidence hydrogen-bonding has a negative impact on conjugation (29) .
Labeling of UGT1A10 expressed in COS-1 cells with [ 33 P]orthophosphate, which was not detected with T73A/T202A/S432G-1A10 triple PKC mutant, confirms the isozyme undergoes phosphorylation most likely by PKC. Further, the progressive decrease in labeling of single and double mutants suggests each predicted PKC site is phosphorylated (Fig. 4) . As S432G mutant exhibited increased and apparently wild-type activity and T73A and T202A mutants were completely inactive, one would expect S432G/T73A and S432G/T202A double mutants to be null.
It is interesting, however, that the two double mutants show additive activity, indicating S432G is different and not the equivalent of wild-type. Furthermore, additive activity suggests phosphate groups are utilized in a hierarchical and/or combinatorial manner in controlling activity (21) . Also, the complete loss of activity of both T73A and T202A demonstrates phosphorylation is required and that both threonines are critical for activity (Figs. 4 and 5) . A comparison of PKC-site mutants in the amino terminus of UGT1A10 and UGT1A1 proved to have null activity, whereas mutants at the site located in the most carboxyl position (S432/S435) caused either an increase (this study) or decrease in activity (21) . One can conclude that phosphorylation at specific sites (T73 and T202) is critical for activity, which will require structural studies to establish site-specific effects. Tables 1B, II and III was determined as described under Experimental Procedures. Sufficient protein was generated to allow the completion of the study. Experiments were repeated thrice in triplicates. 
